Early and Sustained Shift in Headache Day Frequency Following Eptinezumab Treatment in Adults With Migraine for Whom 2–4 Previous Preventive Treatments Have Failed: A Post Hoc Analysis of the Randomized DELIVER Trial

Documenti analoghi

• Long‐Term Improvements Following Initial Migraine Response in Eptinezumab‐Treated Participants With Migraine for Whom 2–4 Prior Preventive Treatments Have Failed
  di: Jessica Ailani, et al.
  Pubblicazione: (2026)
• Long‐term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trial
  di: Anna Gryglas‐Dworak, et al.
  Pubblicazione: (2024)
• Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache
  di: Andrew Blumenfeld, et al.
  Pubblicazione: (2024)
• The Role of Inflammation in Migraine Headaches: A Review
  di: Caryn T. Morgan, et al.
  Pubblicazione: (2025)
• MIDAS and HIT‐6 Questionnaires Versus Headache Diaries for Monitoring Treatment Response to Erenumab in Migraine: A REFORM Study
  di: Janu Thuraiaiyah, et al.
  Pubblicazione: (2026)